Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Danish chemical industry news
4 February 2026
Kemira Enters Finland's Top 5 in Nordic Diversity Index
Kemira improved its diversity ranking, focusing on gender, age, nationality, and education. The 2026 report highlights AI's role in digital leadership.
4 February 2026
Worley Backs AquaDuctus Hydrogen Pipeline in North Sea
AquaDuctus, a key project in Europe's hydrogen infrastructure, will connect offshore production to the mainland, supporting cross-border collaboration and green hydrogen deployment.
2 February 2026
Court Allows Ørsted's Sunrise Wind Project to Resume Construction
A U.S. court lifted a suspension, allowing the Sunrise Wind Project to restart construction, prioritizing safety and aiming to provide reliable power to New York.
2 February 2026
Ørsted Announces New Employee-Elected Board Member
Leticia Mandiola steps down from Ørsted's board. Arul Gynasegaran, Senior Project Lead, replaces her as the new employee-elected board member.
31 January 2026
Novo Nordisk Board Change Announcement
Thomas Rantzau leaves the Board after 22 years. Tanja Villumsen steps in as the new employee representative.
27 January 2026
Statkraft Appoints Tor Lønnum as CFO
Tor Lønnum, with extensive leadership experience, will start as CFO on 1 Feb 2026, succeeding Tone Aastveit Skuterud. He aims to support Statkraft's strategy and renewable energy goals.
How does the Danish chemical industry perform?
Find out with
chemXplore Analytics
Learn more
26 January 2026
Future North Sea Energy System by European Network Operators
Europe's energy shift needs offshore wind and hydrogen integration in the North Sea for decarbonization, affordability, and supply security, requiring clear policies and infrastructure.
26 January 2026
Danish Energy Agency Approves RWE's Thor Offshore Wind Farm
Thor offshore wind farm receives a 30-year production license. Construction is on track, with turbine installation starting this spring. Completion expected in 2027 to power 1M Danish homes.
23 January 2026
Topsoe to Provide Technology for China's Sustainable Aviation Fuel Project
The project will use Hydroflex® technology to produce sustainable aviation fuel, aiming to cut CO2 emissions by 700,000 metric tons annually, with operations starting in 2028.
20 January 2026
Aspect Biosystems and Novo Nordisk Advance Partnership for Diabetes Medicines
The partnership focuses on developing cellular therapies for diabetes, integrating technologies, and expanding manufacturing and R&D capabilities across Canada, the US, and Denmark.
15 January 2026
Topsoe Names Yassir Ghiyati as CCO
Yassir Ghiyati, with over 20 years at Topsoe, becomes CCO, succeeding Elena Scaltritti, who will be CEO. He'll oversee global commercial offerings and innovative technologies.
15 January 2026
Topsoe Names Yassir Ghiyati as CCO
Yassir Ghiyati becomes CCO, succeeding Elena Scaltritti, who will be CEO. Ghiyati has 20+ years in engineering, sales, and leadership, previously VP and MD for EMEA.
7 January 2026
Genmab and Anthropic Collaborate on AI-Driven R&D Enhancement
The partnership aims to streamline R&D with AI, enhancing data processing and document generation to boost efficiency and focus on strategic tasks.
7 January 2026
Grupa Azoty Secures Multi-Year Fertiliser Deal in Scandinavia
The contract enhances export strategy, ensuring stable fertiliser supply to Scandinavia, meeting high standards and boosting sales in a key market.
7 January 2026
Sunrise Wind Challenges Lease Suspension in Court
Sunrise Wind seeks a preliminary injunction against a lease suspension, citing legal violations and project delays, impacting energy supply and jobs.
29 December 2025
Genmab Ends Acasunlimab Development
Genmab shifts focus to high-impact projects in its late-stage pipeline, ensuring no change to 2025 financial guidance.
23 December 2025
Gasunie and Thyssengas Sign First Netherlands-Germany Hydrogen Transport Agreement
New agreements establish key technical and organizational aspects for safe, reliable cross-border hydrogen transport between the Netherlands and Germany.
22 December 2025
Topsoe and Partners Launch Dynamic Green Ammonia Plant in Denmark
The world's first dynamic green ammonia plant in Denmark produces 5,000 tons annually, reducing CO2 by 9,600 tons, using renewable power without hydrogen storage.
18 December 2025
RWE Sells Polish Offshore Wind Project to PGE
RWE sells its 350 MW Baltic II wind project to PGE, closing in Q1 2026. RWE continues to support Poland's energy transition with over 660 MW in onshore wind and solar projects.
18 December 2025
Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment
CagriSema, a weekly injectable combining GLP-1 and amylin analogues, shows promising weight loss results in trials and awaits FDA review for obesity management.
16 December 2025
PPG Secures REDCert² Certification for Sustainable Materials at European Sites
PPG's Amsterdam and Søborg sites achieve REDCert², ensuring sustainable raw material use and supporting customers' environmental goals with high-performance products.
12 December 2025
Topsoe Wins S&P Platts Global Energy Award in Chemicals
Topsoe's sustainable chemical solutions and innovation in energy transition earn recognition at the S&P Platts Global Energy Awards.
9 December 2025
Novo Nordisk Completes Akero Acquisition
Novo Nordisk acquired Akero for $4.7B, with a $0.5B contingent on EFX approval. Akero is now a subsidiary, and its stock is delisted from Nasdaq.
9 December 2025
Topsoe and Carbon Neutral Fuels Collaborate on e-SAF Project with SOEC Technology
Project Starling in the UK will use SOEC technology to produce 25,000 tons of e-SAF annually, aiming for an 89% emissions reduction. Construction starts in 2028, operations by 2031.
4 December 2025
Ørsted's Borkum Riffgrund 3 Offshore Wind Farm in Germany Begins Power Production
Borkum Riffgrund 3 delivers first power to Germany's grid, aiding decarbonization via CPPAs. Full commissioning expected Q1 2026.
26 November 2025
Novo Nordisk Seeks FDA Approval for Higher Dose of Wegovy 7.2 mg
FDA to review semaglutide 7.2 mg for obesity under expedited program. Phase 3 trial shows 20.7% weight loss. Approval offers new weight management option.
25 November 2025
Novo Nordisk Reports Phase 2 Success with Amycretin in Type 2 Diabetes
Amycretin shows significant HbA1c reduction and weight loss in type 2 diabetes patients, with a safe profile. Phase 3 trials planned for 2026.
24 November 2025
Novo Nordisk: Phase 3 Trials Show No Significant Impact on Alzheimer's Progression
Semaglutide showed no significant effect on Alzheimer's progression in phase 3 trials, despite improving biomarkers. Trials will not continue due to lack of efficacy.
14 November 2025
Novo Nordisk Board Changes at Extraordinary General Meeting
New board members elected, including Lars Rebien Sørensen as chair and Cees de Jong as vice chair, with a focus on supporting management and engaging with shareholders.
13 November 2025
Novo Nordisk: Mikael Dolsten Withdraws Board Candidacy
Mikael Dolsten won't seek election to the Board due to personal reasons. No replacement will be proposed until the Annual General Meeting in March 2026.
Next →
